Following recommendation from the Centers for Disease Control and Prevention and the U.S. Food and Drug Administration, the Texas Department of State Health Services asked all Texas COVID-19 vaccine providers Tuesday to pause administration of the Johnson & Johnson/Janssen vaccine.
The DSHS said the pause is recommended after six individuals reported blood clots between six and 13 days after receiving the Johnson & Johnson vaccine. These after effects appear to be extremely rare and are being further evaluated to ensure vaccine safety, the DSHS added.
"The State of Texas is working in tandem with the federal government and vaccine providers to temporarily pause all administration of the Johnson & Johnson vaccine,” Gov. Greg Abbott said in a statement. “While no cases of blood clots have been reported in Texas, we are taking the reports of rare adverse effects seriously and are working to ensure that COVID-19 vaccines administered in our state continue to be safe and effective.